Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Food Funct ; 9(4): 2043-2050, 2018 Apr 25.
Artigo em Inglês | MEDLINE | ID: mdl-29570193

RESUMO

Stimulating the browning of white adipocytes contributes to the restriction of obesity and related metabolic disorders. This study aimed to investigate the browning effects of phytol on mice inguinal subcutaneous white adipose tissue (iWAT) and explore the underlying mechanisms. Our results demonstrated that phytol administration decreased body weight gain and iWAT index, and stimulated the browning of mice iWAT, with the increased expression of brown adipocyte marker genes (UCP1, PRDM16, PGC1α, PDH, and Cyto C). In addition, phytol treatment activated the AMPKα signaling pathway in mice iWAT. In good agreement with the in vivo findings, the in vitro results showed that 100 µM phytol stimulated brown adipogenic differentiation and formation of brown-like adipocytes in the differentiated 3T3-L1 by increasing the mitochondria content and oxygen consumption, and promoting mRNA and/or protein expression of brown adipocyte markers (UCP1, PRDM16, PGC1α, PDH, Cyto C, Cidea and Elovl3) and beige adipocyte markers (CD137 and TMEM26). Meanwhile, phytol activated the AMPKα signaling pathway in the differentiated 3T3-L1. However, the inhibition of AMPKα with Compound C totally abolished phytol-stimulated brown adipogenic differentiation and formation of brown-like adipocytes. In conclusion, these results showed that phytol stimulated the browning of mice iWAT, which was coincident with the increased formation of brown-like adipocytes in the differentiated 3T3-L1, and appeared to be primarily mediated by the AMPKα signaling pathway. These data provided new insight into the role of phytol in regulating the browning of WAT and suggested the potential application of phytol as a nutritional intervention for the restriction of obesity and related metabolic disorders.


Assuntos
Proteínas Quinases Ativadas por AMP/metabolismo , Adipócitos Bege/metabolismo , Fármacos Antiobesidade/uso terapêutico , Suplementos Nutricionais , Obesidade/prevenção & controle , Fitol/uso terapêutico , Gordura Subcutânea Abdominal/metabolismo , Células 3T3-L1 , Proteínas Quinases Ativadas por AMP/antagonistas & inibidores , Proteínas Quinases Ativadas por AMP/química , Adipócitos Bege/efeitos dos fármacos , Adipócitos Bege/patologia , Adipogenia/efeitos dos fármacos , Adiposidade , Animais , Fármacos Antiobesidade/antagonistas & inibidores , Fármacos Antiobesidade/metabolismo , Biomarcadores/metabolismo , Dieta Hiperlipídica/efeitos adversos , Ativação Enzimática/efeitos dos fármacos , Regulação da Expressão Gênica no Desenvolvimento/efeitos dos fármacos , Metabolismo dos Lipídeos/efeitos dos fármacos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Obesidade/etiologia , Obesidade/metabolismo , Obesidade/patologia , Fitol/antagonistas & inibidores , Fitol/metabolismo , Inibidores de Proteínas Quinases/farmacologia , Distribuição Aleatória , Transdução de Sinais/efeitos dos fármacos , Gordura Subcutânea Abdominal/efeitos dos fármacos , Gordura Subcutânea Abdominal/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA